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Abstract
The ubiquitin proteasome pathway regulates the expression of major cellular regulatory proteins. The ubiquitin
proteasome system has been demonstrated to be involved in the expression of the cyclin kinase inhibitor, p21. Ubiquitinated
p21 is degraded immediately by 26S proteasome, therefore, the detection of p21 is difficult. We report here an improvement
for the detection of ubiquitinated p21 using a proteasome inhibitor, clasto-lactacystin L-lactone. A p21-enriched cell lysate is
obtained by pretreating the cells with deferoxamine to induce p21 mRNA expression followed by treatment with 1U1036 M
L-lactone. The concentration of p21 from the cell lysate was performed using an anti-p21 antibody crosslinked to protein G
Sepharose. Ubiquitinated p21 was detected on Western blots of the concentrated sample using an anti-ubiquitin antibody.
This detection system will be used for further analysis of the regulation of p21 ubiquitination. ß 1999 Elsevier Science B.V.
All rights reserved.
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The ubiquitin proteasome degradation pathway
has been shown to involve short-lived proteins [1],
p53 [2], p27KIP1 [3], and cyclins [4]. Once ubiquitin
is ligated on a target protein, the ubiquitinated pro-
tein is immediately recognized and degraded by the
26S proteasome [5]. This rapid degradation results in
di⁄culty in the detection of ubiquitinated protein in
cell lysate. Accordingly, the role of the ubiquitin-pro-
teasome pathway in protein degradation has been
suggested by the stabilization of target proteins using
proteasome inhibitors [6^8]. Using proteasome inhib-
itors and demonstrating ubiquitinated protein, the
expression of p21, a cyclin kinase-dependent kinase
inhibitor, has been reported to be regulated by the
ubiquitin^proteasome system [9^12].
Previously, we reported that treatment of the ML-
1 human myelocytic leukemia cell line (supplied by
the Health Science Research Resource Bank; ex-
pressing wild-type functional p53) with deferoxamine
B mesylate, an iron chelator, (deferoxamine Mr
656.8, Ciba-Geigy, Basle, Switzerland), results in ac-
cumulated p53 protein and p21 mRNA, but not p21
product [13]. However, treatment of cells with etopo-
side, a DNA-damaging agent, results in p53 accumu-
lation, p21 induction and inhibition of phosphoryla-
tion of pRB [13]. Analysis of the subcellular location
of p21 mRNA revealed that p21 mRNA was present
0167-4889 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 9 9 ) 0 0 0 8 1 - 6
* Corresponding author. Fax: +81-3-3788-4927;
E-mail : kfukuchi@med.showa-u.ac.jp
BBAMCR 10406 30-7-99
Biochimica et Biophysica Acta 1451 (1999) 206^210
www.elsevier.com/locate/bba
in the polysome fraction either in deferoxamine or in
etoposide treatment [12]. These results suggest that
the degradation mechanism of p21 functions when
p21 mRNA is induced by deferoxamine treatment
[12]. To con¢rm the involvement of the ubiquitin^
proteasome degradation pathway in p21 expression,
we treated ML-1 cells with deferoxamine and lacta-
cystin. As a result, p21 expression was enhanced and
ubiquitinated p21 was observed [12]. However, the
detection level of ubiquitinated p21 was not adequate
for further analysis of the regulation of ubiquitina-
tion [12].
In this study, we applied clasto-lactacystin L-lac-
tone (L-lactone; Boston Biochem, MA), a derivative
of lactacystin, to stabilize p21. In vitro, lactacystin is
reported not to react with the proteasome directly;
rather, it undergoes a spontaneous conversion (lacto-
nization) to the active proteasome inhibitor, L-lac-
tone [14]. Only L-lactone, not lactacystin, can enter
the cell rapidly and inhibit the proteasome [14]. We
report here that by utilizing L-lactone as a protea-
some inhibitor and using an anti-p21 antibody cross-
linked to protein G Sepharose to precipitate p21,
ubiquitinated p21 is detectable as strong bands on
Western blots using anti-ubiquitin antibody
(DAKO, Denmark).
Initially, we determined the optimal concentration
of proteasome inhibitors for p21 expression using
ML-1 cells. Cells were cultured in RPMI 1640 con-
taining 10% fetal calf serum at the concentration
between 2U105 to 1U106 cells/ml. ML-1 cells in ex-
ponential growth were prepared by seeding the cells
at a concentration of 2U105 cells/ml 24 h prior to
treatment.
Expression of p21 was evaluated after a 1^6 h in-
cubation in 1^10U1036 M of either L-lactone or lac-
tacystin (kindly provided by Dr. S. Omura, Kitasato
Institute. Stock solutions of lactacystin and L-lactone
were prepared in dimethyl sulfoxide (DMSO) at the
concentrations of 1U1032 M. The e¡ective concen-
tration was observed at 2U1036 M for lactacystin
and 1U1036 M for L-lactone at 2^3 h (data not
shown).
The e¡ect of proteasome inhibitors on the p21 ex-
pression was evaluated by Western blot analysis of
treated cell lysates as described previously. Cells
(2U107) were washed with ice-cold phosphate-bu¡-
ered saline (PBS), pH 7.4, then lysed in 1 ml of lysis
bu¡er (1% Nonidet P-40, 1U1032 M sodium phos-
phate, pH 7.2, 1.5U1031 M NaCl, 1U1033 M
EDTA, 5U1032 M sodium £uoride, 1U1032 M so-
dium orthovanadate, 2 Wg/ml aprotinin, 2 Wg/ml leu-
peptin, 5 Wg/ml phenyl methylsulfonyl £uoride and
60 Wg/ml N-ethylmaleimide). After incubation on ice
for 30 min, the lysate was clari¢ed by ultracentrifu-
gation at 105 000Ug for 1 h at 4‡C. The protein
concentration of cell lysate was determined using
the Bradford method [15]. We compared p21 expres-
sion in cells treated with either 2U1036 M lactacystin
or 1U1036 M L-lactone after 3 h incubation (Fig. 1).
An equivalent amount of cell lysate (30 Wg) from
each incubation was subjected to 10^20% SDS poly-
acrylamide gel electrophoresis (SDS-PAGE) using
2.5U1032 M Tris-HCl, pH 8.3, 1.92U1031 M gly-
cine 0.1% SDS as a bu¡er. The gels were electroblot-
ted (250 mA 2 h) on an PVDF membrane (Bio-Rad,
Hercules, CA) in 2.5U1032 M Tris-HCl, pH 8.3,
1.92U1031 M glycine and 20% methanol. The mem-
branes were pre-incubated in 10% non-fat dry milk
in PBS, then incubated in a dilution of anti-p21 pol-
yclonal antibody (H164; 1:200, Santa Cruz Biotech-
nology, Santa Cruz, CA). The blot was washed in
2U1033 M Tris-HCl, pH 7.5, 5U1031 M NaCl,
0.5% Tween 20 (TTBS) to remove unbound antibody
followed by an incubation in diluted biotinylated
anti-rabbit IgG. The membrane was again washed
with TTBS and incubated in a dilution of strepto-
avidin^biotinylated alkaline phosphatase complex,
which binds to the biotin conjugated to the second-
ary antibody. After washing thoroughly, NBT/X-
phosphate substrate was used to visualize the bands.
Results from these experiments reveal that L-lac-
tone treatment is more e¡ective in the increase of p21
expression than treatment with lactacystin. These re-
sults may be due to the ability of L-lactone to enter
the cell directly and inhibit the proteasome, while
lactacystin must be metabolized prior to entering
the cell [14].
Since L-lactone treatment is the most e⁄cient, we
chose to examine p21 expression after pretreatment
of the cells with deferoxamine. Recently, we reported
that incubation of 1U1034 M deferoxamine for 6 h
resulted in a 400% increase of p21 mRNA without a
detectable increase in p21 protein expression [13].
Therefore, to detect an increase in p21 protein levels,
we exposed ML-1 cells that had been pretreated for
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4 h with 1U1034 M deferoxamine to 2U1036 M
L-lactone for 2 h. As shown in Fig. 2, the p21 ex-
pression after treatment with deferoxamine alone was
faint. However, the level of p21 expression was en-
hanced in ML-1 cells treated with the combination of
L-lactone and deferoxamine. In addition, the p21
levels were higher in cells treated with the combina-
tion of agents than in those treated with L-lactone
alone. This observation suggests that increased p21
results from an increase in p21 mRNA due to defer-
oxamine treatment. All of these results suggest that
the ubiquitinated p21 is present and detectable in the
lysate of cells treated with a combination of L-lac-
tone and deferoxamine.
If proteasome inhibition and enhanced p21 protein
expression result in detectable p21 expression as
demonstrated above, then these methods may be
used for detection of ubiquitinated p21 protein. First,
to isolate and concentrate the p21 protein, we cross-
linked anti-p21 antibody to protein G Sepharose.
Fifty micrograms of anti-p21 polyclonal antibody
(H164) and 0.5 ml of 50% slurry protein G Sephar-
ose (Pharmacia, Uppsala, Sweden) were incubated in
PBS at 4‡C for 1 h. Antibody-bound protein G Seph-
arose was washed with ice cold PBS two times, then
equilibrated in 1 ml of 2U1031 M sodium borate.
Dimethyl-pimelimidate (5.2 mg) was added to the
suspended antibody bound protein G Sepharose
and incubated at 20‡C for 30 min with moderate
mixing. The antibody crosslinked protein G Sephar-
ose was washed with 2U1031 M ethanolamine two
times then equilibrated in 0.5 ml PBS containing
0.1% sodium azide. The antibody crosslinked protein
G Sepharose was stored in 4‡C until used.
Due to the low levels of the ubiquitinated p21, we
concentrated the p21 molecules in lysate from 2U108
cells. Cell lysate from 2U108 cells was immunopre-
cipitated with 40 Wl of anti-p21 antibody crosslinked
protein G Sepharose for 1 h at 20‡C. After washing
with PBS three times, the trapped p21 molecule was
eluted with 20 Wl of 1U1032 M Tris-HCl, pH 6.8, 1%
SDS at 55‡C for 5 min. The eluted samples were
divided into two aliquots which were electrophoresed
and electroblotted as described above. After block-
ing, membranes were incubated with anti-p21 poly-
clonal antibody (H164; 1:200) or anti-ubiquitin pol-
yclonal antibody (1:200, DAKO, Denmark). The
blot was washed and the alkaline phosphatase was
detected as described.
During electrophoresis, p21 ligated with one mol-
ecule of ubiquitin, Mr 8600, will migrate with a mo-
lecular weight equivalent to 30 kDa, which is similar
in size to the immunoglobulin light chain. Conse-
quently, when p21 molecules are eluted from the
antibody-conjugated Sepharose beads using bu¡er
containing L-mercaptoethanol, eluted immunoglobu-
lin light chain will co-migrate with the ubiquinated-
p21 and make its detection di⁄cult. Therefore, we
used an elution bu¡er containing 1% SDS without
L-mercaptoethanol.
On Western blots of eluted protein from lysate of
cells treated with the combination of deferoxamine
and L-lactone, the anti-p21 antibody detected a dense
21 kDa band and speci¢c high molecular weight
bands (Fig. 3 left). When Western blots of eluted
protein from lysate of cells treated with deferoxamine
alone were probed with anti-p21 antibodies, only a
faint p21 band was observed. Anti-ubiquitin antibod-
Fig. 1. p21 expression after treatment with proteasome inhibi-
tors. Exponentially growing ML-1 cells were treated with
2U1036 M lactacystin or 1U1036 M L-lactone for 3 h. Cell ly-
sates (30 Wg) were electrophoresed on 10^20% SDS-PAGE,
blotted to PVDF membrane, then probed with anti-p21 poly-
clonal antibody.
Fig. 2. p21 expression induced by L-lactone is enhanced by pre-
treatment of cells with deferoxamine. Exponentially growing
ML-1 cells were treated with 1U1034 M deferoxamine for 4 h,
followed by 1U1036 M L-lactone for 2 h, or 1U1034 M defer-
oxamine alone for 6 h. Cell lysates (30 Wg) were electrophoresed
on 10^20% SDS-PAGE then blotted onto PVDF membrane.
The membrane was probed with anti-p21 polyclonal antibody.
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ies also detected the high molecular weight bands
observed above using the anti-p21 antibody (Fig. 3,
right). The estimated sizes of high molecular sized
bands were W30 kDa, W39 kDa, W48 kDa and
W56 kDa, corresponding to the p21 protein with
increasing numbers of bound ubiquitin molecules.
The band intensity detected with the anti-ubiquitin
antibody was related to the number of ligated ubiq-
uitin molecules, and the W30 kDa band (possessing
a single ubiquitin molecule) was faint.
It is now possible to detect clear ubiquitinated p21
molecules by stabilization with L-lactone followed by
concentration of p21 molecules using anti-p21 anti-
bodies crosslinked to protein G Sepharose. Cur-
rently, using this detection system, we are investigat-
ing the ubiquitination signal of p21.
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